In clinical diagnosis, especially in respiratory medicine, which receives more patients with respiratory diseases, we can often see some professional terms such as "interstitial lesions" and "interstitial changes of the lungs" in some examination reports. After seeing these very strange diagnoses, ordinary people often worry about whether their lung diseases are too serious to be treated. After consulting a doctor in the hospital, due to the relatively complicated medical environment, doctors can't guarantee too many therapeutic effects, which will inevitably make patients more worried about their current disease evolution, so they often see some patients consulting or asking about the prognosis and treatment of pulmonary interstitial diseases on the Internet. So, what exactly is pulmonary interstitial disease? How critical is it? Is pulmonary interstitial disease really as incurable as people say?
To understand this problem, we must first understand the composition of pulmonary interstitial. In medical anatomy, pulmonary interstitial tissue is defined as the tissue between alveoli, that is, the supporting system between alveoli composed of blood vessels, connective tissue, nerve tissue and lymphatic tissue structure. Patients with pulmonary interstitial diseases often have dyspnea, cough, expectoration, cyanosis of mouth, lips and face, and severe cases may have shock symptoms.
Interstitial pneumonia is induced by many reasons, resulting in more than 200 interstitial diseases. According to the pathological changes involved in interstitial pneumonia, the pulmonary interstitial damage caused by interstitial pneumonia can be divided into four stages: stage I-stage IV. When the third stage pulmonary interstitial disease is serious, the alveolar septum is destroyed and the collagen tissue is broken, which is very important. Is there really no medicine to cure it? Not really. At this stage, glucocorticoid shock therapy should be widely used to reduce inflammatory exudation caused by pulmonary interstitial changes. In order to avoid the occurrence of pulmonary fibrosis, adequate glucocorticoid treatment must be given in advance. If interstitial lung injury is serious and secondary infection occurs during this period, antibiotics should be given for symptomatic treatment.
Pulmonary interstitial disease belongs to "lung arthralgia" disease in traditional Chinese medicine. Traditional Chinese medicine mainly adopts some symptomatic treatment schemes such as dispersing lung, promoting diuresis and resolving phlegm, and its treatment effect is also ideal. If the effect of glucocorticoid treatment is not ideal in the later stage, traditional Chinese medicine can be used to cooperate. Therefore, it can be considered that although the symptoms of pulmonary interstitial disease are serious, as long as the pulmonary interstitial disease is still in a vague changing period or caused by a clear cause, symptomatic treatment according to the situation can be effectively solved.
Finally, pulmonary interstitial diseases are highly related to smoking and unhealthy working environment, and smokers should quit smoking in time.